The invention relates to novel dihydropyridinone derivatives, processesfor their preparation, and their use in medicaments, especially for thetreatment ofchronic obstructive pulmonary diseases, acute coronary syndrome, acutemyocardialinfarction and heart failure development.In a specific embodiment, the invention relates to a compound of thegeneral formula (I)(see formula I)or a salt, hydrate and/or solvate thereof, or a tautomeric form thereof,whereinR1 and R3 independently from each other represent hydrogen, halogen,nitro, etc.,R6 represents- a group of the formula(see formula II)which can be substituted by up to two radicals independently selected from thegroupconsisting of C1-C6-alkyl, C1-C6-alkoxy, hydroxycarbonyl, etc.,- a group of the formula(see formula III) or (see formula IV)which are substituted by one or two radicals independently selected from thegroupconsisting of C1-C6-alkyl, hydroxy, C1-C6-alkoxy,etc.
